Y-mAbs Therapeutics (YMAB) PT Lowered to $67 at Wedbush, Following Earnings
Tweet
Share
E-mail
Get Alerts YMAB Hot Sheet
Price: $26.22 -3.96%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Wedbush analyst David Nierengarten lowered the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $67.00 (from $71.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Alliance Bancorporation (WAL) PT Raised to $125 at Wedbush, Following Earnings
- Industrial Bank of Korea (024110:KS) PT Raised to KRW10,000 at Morgan Stanley
- Localiza Rent a Car S.A. (RENT3:BZ) (LZRFY) PT Lowered to R$67 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
